Speakup About Drugs
EIN: 823425247 · Rogers, AR · NTEE: F20
| Metric | Value |
|---|---|
| Total Revenue | $105K |
| Total Expenses | $115K |
| Net Assets | $-24,974 |
Is Speakup About Drugs Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Speakup About Drugs
Speakup About Drugs (EIN: 823425247) is a nonprofit organization based in Rogers, AR, classified under NTEE code F20. The organization reported total revenue of $105K and total assets of $26K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Speakup About Drugs's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Speakup About Drugs is a small nonprofit that has been operating for 9 years, with 2 years of IRS 990 filings on record (2022–2023). Revenue has grown at a compound annual rate of -51.9%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $78K |
| Total Expenses | $115K |
| Surplus / Deficit | $-37,665 |
| Total Assets | $34K |
| Total Liabilities | $59K |
| Net Assets | $-24,974 |
| Operating Margin | -48.5% |
| Debt-to-Asset Ratio | 173.1% |
| Months of Reserves | 3.6 months |
Financial Health Grade: C
In 2023, Speakup About Drugs reported a deficit of $38K with expenses exceeding revenue, holds 3.6 months of operating reserves (adequate), has a debt-to-asset ratio of 173.1% (high leverage).
Financial Trends
Over 2 years of filings (2022–2023), Speakup About Drugs's revenue has declined at a compound annual growth rate (CAGR) of -51.9%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -51.9% | -30.7% | -38.9% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2017 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Speakup About Drugs has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Speakup About Drugs with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $38K, with expenses exceeding revenue.
- Debt-to-asset ratio: 173.1%.
Frequently Asked Questions about Speakup About Drugs
Is Speakup About Drugs a legitimate charity?
Speakup About Drugs (EIN: 823425247) is a registered tax-exempt nonprofit based in Arkansas. It has 2 years of IRS 990 filings on record. Total revenue: $105K. No red flags identified. Financial health grade: C.
How does Speakup About Drugs spend its money?
Speakup About Drugs reported $105K in total revenue in IRS 990 filings. 2 years of filing data available. Expenses exceeded revenue in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to Speakup About Drugs tax-deductible?
Speakup About Drugs is registered as a tax-exempt nonprofit (EIN: 823425247). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Speakup About Drugs located?
Speakup About Drugs is headquartered in Rogers, Arkansas and files with the IRS under EIN 823425247. It is classified under NTEE code F20.
How many years of IRS 990 filings does Speakup About Drugs have?
Speakup About Drugs has 2 years of IRS 990 filings on record at NonprofitSpending. Additional filing years may become available as the IRS releases new data. The most recent filing shows $105K in total revenue.
Filing History
IRS 990 filing history for Speakup About Drugs showing financial trends over 2 years of public records:
Over 2 years of IRS 990 filings (2022–2023), Speakup About Drugs's revenue has declined by 51.9%, moving from $162K to $78K. Total assets decreased by 38.9% over the same period, from $56K to $34K. Total functional expenses fell by 30.7%, from $166K to $115K. In its most recent filing year (2023), Speakup About Drugs reported a deficit of $38K, with expenses exceeding revenue. The organization holds $59K in liabilities against $34K in assets (debt-to-asset ratio: 173.1%), resulting in net assets of $-24,974.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $78K | $115K | $34K | $59K | — | — |
| 2022 | $162K | $166K | $56K | $43K | — | — |
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Speakup About Drugs:
Data Sources and Methodology
This transparency report for Speakup About Drugs is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.